The Effect of n-3 Polyunsaturated Fatty Acids on Plasma Lipids and Lipoproteins in Patients With Chronic Renal Failure-A Meta-Analysis of Randomized Controlled Trials

Journal of Renal Nutrition

Volumn 22, Issue 6, 2012, Pages 525-532

  Pei, Jiao ^a   Zhao, Yiyang ^b   Huang, Lujiao ^a   Zhang, Xingyu ^a   Wu, Yang ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

BLOOD; CHRONIC KIDNEY FAILURE; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

CHOLESTEROL, HDL; CHOLESTEROL, LDL; FATTY ACIDS, OMEGA-3; FISH OILS; HUMANS; KIDNEY FAILURE, CHRONIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84867984754     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2012.04.005     Document Type: Review

References (37)

1. Donnelly S.M., Ali M.A., Churchill D.N. Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. J Am Soc Nephrol 1992, 2:1634-1639.
2. Cappelli P., Di Liberato L., Stuard S. N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease. J Nephrol 1997, 10:157-162.
3. Ando M., Sanaka T., Nihei H. Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. J Am Soc Nephrol 1999, 10:2177-2184.
4. Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr 2000, 10:191-195.
5. Schmitz P.G., Mccloud L.K., Reikes S.T. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol 2002, 13:184-190.
6. Svensson M., Christensen J.H., Sølling J. The effect of n-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis 2004, 44:77-83.
7. Saifullah A., Watkins B.A., Saha C. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant 2007, 22:3561-3567.
8. Svensson M., Schmidt E.B., Jørgensen K.A. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrol Dial Transplant 2008, 23:2918-2924.
9. Bowden R.G., Jitomir J., Wilson R.L. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients. J Ren Nutr 2009, 19:259-266.
10. Bowden R.G., Wilson R.L., Deike E. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease. Nutr Clin Pract 2009, 24:508-512.
11. Bouzidi N., Mekki K., Boukaddoum A. Effects of omega-3 polyunsaturated fatty-acid supplementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr 2010, 20:321-328.
12. Taziki O., Lessan-Pezeshki M., Akha O. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transplant 2007, 18:571-576.
13. Vaziri N.D. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Ren Physiol 2006, 290:262-272.
14. Friedman A., Moe S. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol 2006, 1:182-192.
15. Harper C.R., Jacobson T.A. Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol 2008, 51:2375-2384.
16. Nestel P.J. Fish oil and cardiovascular disease: lipids and arterial function. Am J Clin Nutr 2000, 71(suppl):228S-231S.
17. Carpentier Y.A., Portois L., Malaisse W.J. N-3 fatty acids and the metabolic syndrome. Am J Clin Nutr 2006, 83(suppl):1499S-1504S.
18. Dyerberg J., Bang H.O., Hjørne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975, 28:958-966.
19. Bang H.O., Dyerberg J., Nielsen A.B. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Nutr Rev 1986, 44:143-146.
20. Harris W.S., Connor W.E., Inkeles S.B. Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemia. Metabolism 1984, 33:1016-1019.
21. Connor W.E., DeFrancesco C.A., Connor S.L. N-3 fatty acids from fish oil effects on plasma lipoproteins and hypertriglyceridemic patients. Ann N Y Acad Sci 1993, 14:16-34.
22. Parks J.S., Crouse J.R. Reduction of cholesterol absorption by dietary oleinate and fish oil in African green monkeys. J Lipid Res 1992, 33:559-568.
23. Abbey M., Clifton P., Kestin M. Effect of fish oil on lipoproteins, lecithin: cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990, 10:85-94.
24. Yuan G., Al-Shali K.Z., Hegele R.A. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007, 176:1113-1120.
25. Grund SM, Becker D, Clark LT, et al. National cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). 2002. NIH Publication No. 02-5215.
26. Hokanson J.E., Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
27. Harris W.S. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(suppl):1645S-1654S.
28. Harris W.S., Miller M., Tighe A.P. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 2008, 197:12-24.
29. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757.
30. Harris W.S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989, 30:785-807.
31. Nestel P.J. Effects of n-3 fatty acids on lipid metabolism. Annu Rev Nutr 1990, 10:149-167.
32. Lowrie E.G., Lew N.L. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990, 15:458-482.
33. Iseki K., Yamazato M., Tozawa M. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002, 61:1887-1893.
34. Brown S.A., Brown C.A., Crowell W.A., et al. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs. J Lab Clin Med 2000, 135:275-286.
35. Miller E.R., Juraschek S.P., Appel L.J., et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr 2009, 89:1937-1945.
36. Cano N.J., Heng A.E., Pison C. Multimodal approach to malnutrition in malnourished maintenance hemodialysis patients. J Ren Nutr 2011, 21:23-26.
37. Smith G.I., Atherton P., Reeds D.N., et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial. Am J Clin Nutr 2011, 93:402-412.